These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23701659)

  • 1. Asymmetric pain processing in Parkinson's disease.
    Granovsky Y; Schlesinger I; Fadel S; Erikh I; Sprecher E; Yarnitsky D
    Eur J Neurol; 2013 Oct; 20(10):1375-82. PubMed ID: 23701659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Dopaminergic Medication on Conditioned Pain Modulation in Parkinson's Disease Patients.
    Grashorn W; Schunke O; Buhmann C; Forkmann K; Diedrich S; Wesemann K; Bingel U
    PLoS One; 2015; 10(8):e0135287. PubMed ID: 26270817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to heat pain stimulation in idiopathic Parkinson's disease.
    Nandhagopal R; Troiano AR; Mak E; Schulzer M; Bushnell MC; Stoessl AJ
    Pain Med; 2010 Jun; 11(6):834-40. PubMed ID: 20624238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study.
    Brefel-Courbon C; Payoux P; Thalamas C; Ory F; Quelven I; Chollet F; Montastruc JL; Rascol O
    Mov Disord; 2005 Dec; 20(12):1557-63. PubMed ID: 16078219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic treatment is associated with decreased body weight in patients with Parkinson's disease and dyskinesias.
    Bachmann CG; Zapf A; Brunner E; Trenkwalder C
    Eur J Neurol; 2009 Aug; 16(8):895-901. PubMed ID: 19374662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative and fiber-selective evaluation of pain and sensory dysfunction in patients with Parkinson's disease.
    Chen Y; Mao CJ; Li SJ; Wang F; Chen J; Zhang HJ; Li L; Guo SS; Yang YP; Liu CF
    Parkinsonism Relat Disord; 2015 Apr; 21(4):361-5. PubMed ID: 25630889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperalgesia and laser evoked potentials alterations in hemiparkinson: evidence for an abnormal nociceptive processing.
    Tinazzi M; Recchia S; Simonetto S; Defazio G; Tamburin S; Moretto G; Fiaschi A; Miliucci R; Valeriani M
    J Neurol Sci; 2009 Jan; 276(1-2):153-8. PubMed ID: 18954878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease.
    Adamiak U; Kaldonska M; Klodowska-Duda G; Wyska E; Safranow K; Bialecka M; Gawronska-Szklarz B
    Clin Neuropharmacol; 2010 May; 33(3):135-41. PubMed ID: 20216409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine asymmetry interacts with medication to affect cognition in Parkinson's disease.
    Tomer R; Aharon-Peretz J; Tsitrinbaum Z
    Neuropsychologia; 2007 Jan; 45(2):357-67. PubMed ID: 16876208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic influence on disturbed spatial discrimination in Parkinson's disease.
    Shin HW; Kang SY; Sohn YH
    Mov Disord; 2005 Dec; 20(12):1640-3. PubMed ID: 16092109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
    Parkinson Study Group CALM Cohort Investigators
    Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facilitated temporal summation of pain at spinal level in Parkinson's disease.
    Perrotta A; Sandrini G; Serrao M; Buscone S; Tassorelli C; Tinazzi M; Zangaglia R; Pacchetti C; Bartolo M; Pierelli F; Martignoni E
    Mov Disord; 2011 Feb; 26(3):442-8. PubMed ID: 21462260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dopaminergic treatment on bladder function in Parkinson's disease.
    Winge K; Werdelin LM; Nielsen KK; Stimpel H
    Neurourol Urodyn; 2004; 23(7):689-96. PubMed ID: 15382192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do dyskinesia and pain share common pathophysiological mechanisms in Parkinson's disease?
    Lim SY; Farrell MJ; Gibson SJ; Helme RD; Lang AE; Evans AH
    Mov Disord; 2008 Sep; 23(12):1689-95. PubMed ID: 18709675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermal and mechanical pain thresholds in patients with fluctuating Parkinson's disease.
    Vela L; Cano-de-la-Cuerda R; Fil A; Muñoz-Hellín E; Ortíz-Gutiérrez R; Macías-Macías Y; Fernández-de-Las-Peñas C
    Parkinsonism Relat Disord; 2012 Sep; 18(8):953-7. PubMed ID: 22658653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pain intensity on and off levodopa in patients with Parkinson's disease.
    Nebe A; Ebersbach G
    Mov Disord; 2009 Jun; 24(8):1233-7. PubMed ID: 19412949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.
    Kim HJ; Paek SH; Kim JY; Lee JY; Lim YH; Kim DG; Jeon BS
    Mov Disord; 2009 Feb; 24(3):329-35. PubMed ID: 19006187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nociceptive brain activation in patients with neuropathic pain related to Parkinson's disease.
    Brefel-Courbon C; Ory-Magne F; Thalamas C; Payoux P; Rascol O
    Parkinsonism Relat Disord; 2013 May; 19(5):548-52. PubMed ID: 23462484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pain sensitivity and clinical progression in Parkinson's disease.
    Mylius V; Brebbermann J; Dohmann H; Engau I; Oertel WH; Möller JC
    Mov Disord; 2011 Oct; 26(12):2220-5. PubMed ID: 21766333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.